To CANCER IMMUNITY Home Page

Figure 7

Rejection of IFNGR1 deficient RAD.gR.28 sarcomas following reconstitution of IFN-gamma responsiveness. An MCA sarcoma cell line (RAD.gR.28) from an IFNGR1-/- mouse was transduced either with empty retrovirus (control), a functionally inactive IFNGR1 C-terminal truncation mutant (IFNGR1deltaIC) or wild type IFNGR1. After isolation of homogeneous transduced cell populations, groups of 5 wild type, genetically matched mice were injected with 1 x 106 of each cell type. Tumor growth was quantitated by daily measurement of tumor size [adapted from (54)].

 

Copyright © 2005 by Robert D. Schreiber